Iteos Therapeutics Inc (ITOS)
Iteos Therapeutics Inc (ITOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2025 | 03-2025 | 12-2024 | 09-2024 | 06-2024 | |
| Sales | 0 | 0 | 0 | 0 | 35,000 |
| Gross Profit | N/A | N/A | N/A | N/A | 35,000 |
| Operating Expenses | 83,791 | 40,021 | 49,332 | 48,798 | 49,166 |
| Operating Income | -83,791 | -40,021 | -49,332 | -48,798 | -14,166 |
| Other Income | 6,732 | 6,508 | 12,974 | 5,683 | 9,299 |
| Pre-tax Income | -77,059 | -33,513 | -36,358 | -43,115 | -4,867 |
| Income Tax | 1,670 | 1,100 | 7,354 | 2,243 | 2,261 |
| Net Income Continuous | -78,729 | -34,613 | -43,712 | -45,358 | -7,128 |
| Net Income | $-78,729 | $-34,613 | $-43,712 | $-45,358 | $-7,128 |
| EPS Basic Total Ops | -1.81 | -0.80 | -1.02 | -1.05 | -0.18 |
| EPS Basic Continuous Ops | -1.81 | -0.80 | -1.02 | -1.05 | -0.18 |
| EPS Diluted Total Ops | -1.81 | -0.80 | -1.02 | -1.05 | -0.18 |
| EPS Diluted Continuous Ops | -1.81 | -0.80 | -1.02 | -1.05 | -0.18 |
| EPS Diluted Before Non-Recurring Items | -1.51 | -0.80 | -1.01 | -1.05 | -0.18 |
| EBITDA(a) | $-80,988 | $-42,160 | $-60,528 | $-48,496 | $-11,116 |